Alterations in Gene Expression in Mutant Amyloid Precursor Protein Transgenic Mice Lacking Niemann-Pick Type C1 Protein

被引:8
|
作者
Maulik, Mahua [1 ,2 ]
Thinakaran, Gopal [3 ,4 ,5 ]
Kar, Satyabrata [1 ,2 ,6 ,7 ]
机构
[1] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada
[2] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada
[3] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA
[5] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[6] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada
[7] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada
来源
PLOS ONE | 2013年 / 8卷 / 01期
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
BETA-DEGRADING ENZYMES; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; MOUSE MODEL; A-BETA; CHOLESTEROL ACCUMULATION; TRAFFICKING; PATHOGENESIS; NEURODEGENERATION; HOMEOSTASIS;
D O I
10.1371/journal.pone.0054605
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Niemann-Pick type C (NPC) disease, a rare autosomal recessive disorder caused mostly by mutation in NPC1 gene, is pathologically characterized by the accumulation of free cholesterol in brain and other tissues. This is accompanied by gliosis and loss of neurons in selected brain regions, including the cerebellum. Recent studies have shown that NPC disease exhibits intriguing parallels with Alzheimer's disease, including the presence of neurofibrillary tangles and increased levels of amyloid precursor protein (APP)-derived beta-amyloid (A beta) peptides in vulnerable brain neurons. To evaluate the role of A beta in NPC disease, we determined the gene expression profile in selected brain regions of our recently developed bigenic ANPC mice, generated by crossing APP transgenic (Tg) mice with heterozygous Npc1-deficient mice. The ANPC mice exhibited exacerbated neuronal and glial pathology compared to other genotypes [i.e., APP-Tg, double heterozygous (Dhet), Npc1-null and wild-type mice]. Analysis of expression profiles of 86 selected genes using real-time RT-PCR arrays showed a wide-spectrum of alterations in the four genotypes compared to wild-type controls. The changes observed in APP-Tg and Dhet mice are limited to only few genes involved mostly in the regulation of cholesterol metabolism, whereas Npc1-null and ANPC mice showed alterations in the expression profiles of a number of genes regulating cholesterol homeostasis, APP metabolism, vesicular trafficking and cell death mechanism in both hippocampus and cerebellum compared to wild-type mice. Intriguingly, ANPC and Npc1-null mice, with some exceptions, exhibited similar changes, although more genes were differentially expressed in the affected cerebellum than the relatively spared hippocampus. The altered gene profiles were found to match with the corresponding protein levels. These results suggest that lack of Npc1 protein can alter the expression profile of selected transcripts as well as proteins, and APP overexpression influences cerebral pathology by enhancing changes triggered by Npc1 deficiency in the bigenic line.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Lipid raft abnormalities and subsequent protein trafficking effects in Niemann-Pick type C1
    Kuech, Eva-Maria
    Shammas, Hadeel
    Maalouf, Katia E.
    von Koeckritz-Blickwede, Maren
    Das, Anibh M.
    Naim, Hassan Y.
    FASEB JOURNAL, 2014, 28 (01):
  • [22] Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1
    Campbell, Kiersten
    Cawley, Niamh X.
    Luke, Rachel
    Scott, Katelin E. J.
    Johnson, Nicholas
    Farhat, Nicole Y.
    Alexander, Derek
    Wassif, Christopher A.
    Li, Wenping
    Cologna, Stephanie M.
    Berry-Kravis, Elizabeth
    Do, An Dang
    Dale, Ryan K.
    Porter, Forbes D.
    BIOMARKER RESEARCH, 2023, 11 (01)
  • [23] Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1
    Kiersten Campbell
    Niamh X. Cawley
    Rachel Luke
    Katelin E. J. Scott
    Nicholas Johnson
    Nicole Y. Farhat
    Derek Alexander
    Christopher A. Wassif
    Wenping Li
    Stephanie M. Cologna
    Elizabeth Berry-Kravis
    An Dang Do
    Ryan K. Dale
    Forbes D. Porter
    Biomarker Research, 11
  • [24] Gene Therapy in a Mouse Model of Niemann-Pick Disease Type C1
    Kurokawa, Yoshie
    Osaka, Hitoshi
    Kouga, Takeshi
    Jimbo, Eriko
    Muramatsu, Kazuhiro
    Nakamura, Sachie
    Takayanagi, Yuki
    Onaka, Tatsushi
    Muramatsu, Shin-ichi
    Yamagata, Takanori
    HUMAN GENE THERAPY, 2021, 32 (11-12) : 589 - 598
  • [25] DEFICIENCY OF NIEMANN-PICK C1 PROTEIN EXPRESSION PROTECTS AGAINST DIET-INDUCED GALLSTONE FORMATION IN MICE
    Morales, M. G.
    Amigo, L.
    Castro, J.
    Nervi, F.
    Rigotti, A.
    Zanlungo, S.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S108 - S109
  • [26] Gene Therapy Moves Forward for Niemann-Pick Disease Type C1
    McIvor, R. Scott
    HUMAN GENE THERAPY, 2021, 32 (11-12) : 540 - 540
  • [27] Morphological Alterations of the Cornea in the Mouse Model of Niemann-Pick Disease Type C1
    Hovakimyan, Marine
    Stachs, Oliver
    Reichard, Maria
    Mascher, Hermann
    Lukas, Jan
    Frech, Moritz Johannes
    Guthoff, Rudolf
    Witt, Martin
    Rolfs, Arndt
    Wree, Andreas
    CORNEA, 2011, 30 (07) : 796 - 803
  • [28] Mechanisms of Niemann-Pick type C1 Like 1 protein degradation in intestinal epithelial cells
    Malhotra, Pooja
    Soni, Vinay
    Yamanashi, Yoshihide
    Takada, Tappei
    Suzuki, Hiroshi
    Gill, Ravinder K.
    Saksena, Seema
    Dudeja, Pradeep K.
    Alrefai, Waddah A.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2019, 316 (04): : C559 - C566
  • [29] LIVER X RECEPTOR AGONISTS UP-REGULATE NIEMANN-PICK TYPE C1 AND NIEMANN-PICK TYPE C2 EXPRESSION IN apoE-/- MICE
    Tang, Chao Ke
    Ou, Xiang
    Dai, Xiao Yan
    Hao, Xin Rui
    Cao, Dong Li
    Hu, Yan Wei
    Li, Xiao Xu
    Xiao, Ji
    Liu, Xie Hong
    CELL BIOLOGY INTERNATIONAL, 2008, 32 (03) : S18 - S18
  • [30] The Niemann-Pick C1 protein in recycling endosomes of presynaptic nerve terminals
    Karten, B
    Campenot, RB
    Vance, DE
    Vance, JE
    JOURNAL OF LIPID RESEARCH, 2006, 47 (03) : 504 - 514